The Ribosomal S6 Kinases (RSKs) are a family of serine/threonine kinases that play crucial roles in cellular physiology by mediating signal transduction downstream of the Extracellular Signal-Regulated Kinase (ERK)/Mitogen-Activated Protein Kinase (MAPK) pathway. RSKs are involved in various cellular processes, including cell growth, survival, and proliferation, as well as the regulation of transcription, translation, and cytoskeletal reorganization. These kinases act as pivotal mediators that link extracellular signals to the appropriate cellular responses, highlighting their significance in the maintenance of cellular homeostasis. Functionally, RSKs are characterized by their ability to phosphorylate a wide array of substrates, thereby influencing their activity, stability, or localization, which in turn affects numerous biological outcomes. The precise regulation of RSK activity is essential for ensuring that signal transduction is appropriately executed in response to external and internal cues, facilitating the dynamic control of cellular processes in accordance with environmental and physiological demands.
The activation of RSKs is a highly regulated process that is primarily driven by the ERK/MAPK signaling cascade. Upon stimulation by growth factors, cytokines, or other extracellular signals, the MAPK pathway is activated, culminating in the phosphorylation and activation of ERK1/2. Activated ERK1/2 then phosphorylates RSK on two critical sites: the activation loop of the kinase domain and the hydrophobic motif of the C-terminal domain. This dual phosphorylation is essential for RSK activation, as it induces a conformational change that allows for the full activation of the kinase. Additionally, RSK activation may be further fine-tuned by phosphorylation events mediated by other kinases such as PDK1, which phosphorylates RSK at the activation loop of its N-terminal kinase domain. This intricate network of phosphorylation events ensures the precise activation of RSK, enabling it to phosphorylate target substrates and exert its effects on various cellular functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 is an AMP-activated protein kinase (AMPK) activator that indirectly influences Rsk activity. By activating AMPK, A769662 modulates cellular energy status and downstream signaling pathways, leading to the indirect activation or modulation of Rsk. | ||||||
2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester | 305834-79-1 | sc-479756 | 25 mg | $380.00 | ||
This compound, also called SC79, is an Akt activator that indirectly impacts Rsk activity through the Akt/mTOR pathway. By activating Akt, SC79 promotes the phosphorylation and activation of mTOR, a key regulator of Rsk. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, a calcium ionophore, can indirectly activate Rsk by modulating calcium-dependent signaling pathways. This compound increases intracellular calcium levels, leading to the activation of calcium-dependent kinases and subsequent activation or modulation of Rsk. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin, a widely used antidiabetic drug, indirectly activates Rsk through its effects on AMP-activated protein kinase (AMPK). Metformin activates AMPK, which can then modulate downstream signaling pathways, including those involving Rsk. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, an adenylate cyclase activator, indirectly influences Rsk activity through the cAMP/PKA pathway. Forskolin increases intracellular cAMP levels, activating protein kinase A (PKA), which can subsequently modulate downstream signaling pathways, including those involving Rsk. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA), a phorbol ester, can indirectly activate Rsk through protein kinase C (PKC) activation. PMA activates PKC, which in turn modulates downstream signaling pathways, including those involving Rsk. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin, a calcium ionophore, can indirectly activate Rsk by modulating calcium-dependent signaling pathways. By increasing intracellular calcium levels, ionomycin activates calcium-dependent kinases, leading to the activation or modulation of Rsk. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cyclic AMP (cAMP) is a cell-permeable analog of cAMP that can indirectly activate Rsk through the cAMP/PKA pathway. Dibutyryl cAMP increases intracellular cAMP levels, activating PKA, which can subsequently modulate downstream signaling pathways, including those involving Rsk. | ||||||